WC
WST icon

Westerkirk Capital’s West Pharmaceutical WST Stock Holding History

Westerkirk Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$357K Hold
995
– – 0.03% 170
2026
Q1 		$249K Buy
995
+100
+11% +$24.9K 0.03% 185
2025
Q4 		$246K Buy
895
+100
+13% +$27.4K 0.02% 193
2025
Q3 		$209K Hold
795
– – 0.02% 224
2025
Q2 		$174K Buy
+795
New +$170K 0.02% 217

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Westerkirk Capital's WST Position: Q2 2026 in Review

Westerkirk Capital held its West Pharmaceutical (WST) position steady in Q2 2026 at 995 shares worth $357K. The position accounts for 0.03% of the portfolio, ranked #170.

Westerkirk Capital first reported a position in WST in Q2 2025 and has held it in 5 quarters since. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Westerkirk Capital held 995 shares of West Pharmaceutical worth $357K as of Q2 2026.
  • Westerkirk Capital left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.03% of Westerkirk Capital's portfolio in Q2 2026, its #170 holding.
  • Westerkirk Capital first reported a position in West Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Westerkirk Capital's 13F filing for Q2 2026, filed 10 Aug 2026.